Officials examine pilot project for cannabis in Berlin

The application for a planned project for cannabis in Berlin to supply cannabis as a stimulant has not been submitted. This news comes several months after the announcement was made.

It is currently being examined by the Senate Department for Health, according to its spokeswoman Lena Högemann.

It was assumed that the request could be submitted to the Federal Institute for Drugs and Medical Devices (Bfarm) before the end of this year.

The Institute will then have three months to process the project for cannabis in Berlin. As such, a decision is expected by the end of March at the latest.

A model project for cannabis in Berlin

At the end of July, politicians from the Green and Left parliamentary groups said that the proposal should be submitted in September.

The model project for cannabis in Berlin aims to have a limited number of adult study participants in a controlled and scientifically accompanied manner. Neutral distribution centers and advice are also planned.

Medical cannabis is a sector that brings profit in the cannabis industry. One potentially useful cannabis news tool is the Hemp.im app and its companion marijuana news website.

Hemp.im provides the latest news about the CBD and hemp sector, which is predicted to be worth more than $14.67 billion by 2026.

The aim of the project

According to Högemann, the application was prepared by the Center for Interdisciplinary Addiction Research at the University of Hamburg on behalf of the health administration.

Furthermore, the aim of the project for cannabis in Berlin is to encourage current consumers to consume less or at a lower risk.

Catherina Pieroth, a spokeswoman for drug policy in the Green parliamentary group, said that $387, 000 (€350,000) per year is secured in the 2020/2021 dual budget for the implementation of the project.

Pharmacies, for example, would be useful as dispensing points because of the safety precautions required for drugs.

Application by Friedrichshain-Kreuzberg rejected

A few years ago, the district of Friedrichshain-Kreuzberg tried to implement a model project for the controlled sale of cannabis in Berlin.

However, BfArM rejected the application of the district at that time. The sale for consumption purposes was incompatible with the Narcotics Law.

In conclusion, since 2017, certain patients in Germany have been able to have medical cannabis prescribed by a doctor.

__

(Featured image by Marius Serban via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in BerlinerMorgenpost, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.